Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches
Source: SeekingAlpha
2026-02-05 14:45:38 ET
More on Qiagen
- Qiagen N.V. (QGEN) Q4 2025 Earnings Call Transcript
- Qiagen N.V. 2025 Q4 - Results - Earnings Call Presentation
- Qiagen: Takeover Optionality With A High-Quality Consumables Platform
- Qiagen Q4 2025 Earnings Preview
- Agilent, Danaher could be potential buyers of Qiagen - analyst
Read the full article on Seeking Alpha
For further details see:
Qiagen targets 9% growth in 2026 growth pillars and $2B by 2028 with new product launches
Qiagen N.V.
NASDAQ: QGEN
QGEN Trading
-3.29% G/L:
$40.52 Last:
1,510,646 Volume:
$41.15 Open:
QGEN Latest News
March 10, 2026 05:05:00 pm
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
QGEN Stock Data
$10,633,318,293
203,932,295
N/A
22
N/A
Biotechnology & Life Sciences
Healthcare
NL
Venlo
